BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ciprofibrate
,
rs3825942
,
VEGFA
,
Metabolism of xenobiotics
,
Diabetes mellitus
,
Neuron
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
h 37
Summary
General Info
Curated Studies
Most Correlated Studies
Hepatocellular carcinoma HCCLM3 cells with shRNA knockdown of KIAA1429
Hepatic progenitor cells, hepatoblasts, and adult hepatocytes transformed with H-Ras and SV40LT
Expression profiling of GATA-1 wild type and mutant fetal megakaryocytes
Endometrial cancer cells (Ishikawa) after short time high dose exposure to progestins
Non-malignant fallopian tube epithelium and high grade serous carcinoma
Explore Curated Studies Results
Literature
Most Relevant Literature
AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma.
Closed Reduction, Arthrogram and Spica Application for DDH.
AKR1C1 connects autophagy and oxidative stress by interacting with SQSTM1 in a catalytic-independent…
Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling.
AKR1C1 Protects Corneal Epithelial Cells Against Oxidative Stress-Mediated Ferroptosis in Dry Eye.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Concomitant Versus Hybrid Regimen for H. Pylori Eradication
The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H.…
Epidemiology of H. Pylori Transmission
The Predict H Trial
Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ